Literature DB >> 5936944

An evaluation of vasodilator drugs in occlusive vascular disease by measurement.

J A Gillespie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5936944     DOI： 10.1177/000331976601700503

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


× No keyword cloud information.
  4 in total

1. 

Authors:  C Diehm; H Heidrich; F Spengel; K L Schulte; W Theiss
Journal:  Internist (Berl)       Date:  2000-11       Impact factor: 0.743

2.  Peripheral vasodilator drugs.

Authors: 
Journal:  Br Med J       Date:  1969-07-05

3.  Current therapy for intermittent claudication.

Authors:  M Verstraete
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

4.  Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.

Authors:  D Angerbach; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.